Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07069036
PHASE1
A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers
Sponsor: Septerna, Inc.
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-631 in healthy adult volunteers.
Official title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of SEP-631 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2025-07
Completion Date
2026-04
Last Updated
2025-07-16
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
SEP-631
Oral, tablet
OTHER
Placebo
Oral, tablet